Effect of aging on magnetic resonance measures differentiating progressive supranuclear palsy from Parkinson's disease

Movement Disorders

Volumn 29, Issue 4, 2014, Pages 488-495

  Morelli, Maurizio ^a   Arabia, Gennarina ^a   Messina, Demetrio ^b   Vescio, Basilio ^c   Salsone, Maria ^a   Chiriaco, Carmelina ^c   Perrotta, Paolo ^c   Rocca, Federico ^c   Cascini, Giuseppe Lucio ^a   Barbagallo, Gaetano ^a   Nigro, Salvatore ^c   Quattrone, Aldo ^a,c  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^c CNR   (Italy)

Author keywords

Aging; Magnetic resonance Parkinsonism index; Midbrain area pons area ratio; Parkinson's disease; Progressive supranuclear palsy

Indexed keywords

ADULT; AGED; AGING; ARTICLE; BRAIN STEM; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MESENCEPHALON; MIDDLE AGED; MIDDLE CEREBELLAR PEDUNCLE; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SCANNER; PARKINSON DISEASE; PONS; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; VERY ELDERLY; AGE; DIFFERENTIAL DIAGNOSIS; IMAGE PROCESSING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

AGE FACTORS; AGED; AGING; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MESENCEPHALON; MIDDLE AGED; PARKINSON DISEASE; PONS; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 84898058879     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25821     Document Type: Article

References (36)

1. Adolfsson R, Gottfries CG, Roos BE, Winblad B. Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature. J Neural Transm 1979;45:81-105.
2. Doraiswamy PM, Na C, Husain MM, et al. Morphometric changes of the human midbrain with normal aging: MR and stereologic findings. AJNR Am J Neuroradiol 1992;13:383-386.
3. Anglade P, Vyas S, Hirsch EC, Agid Y. Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging. Histol Histopathol 1997;12:603-610.
4. Dreher JC, Meyer-Lindenberg A, Kohn P, Berman KF. Age-related changes in midbrain dopaminergic regulation of the human reward system. Proc Natl Acad Sci U S A 2008;105:15106-15111.
5. Sohmya M, Tanaka M, Aihara Y, Hirai S, Okamoto K. Age-related structural changes in the human midbrain: an MR image study. Neurobiol Aging 2001;22:595-601.
6. Sohmya M, Tanaka M, Aihara Y, Okamoto K. Structural change in the midbrain with aging and Parkinson's disease: an MRI study. Neurobiol Aging 2004;25:449-453.
7. Brickman AM, Habeck C, Zarahn E, Flynn J, Stern Y. Structural MRI covariance patterns associated with normal aging and neuropsychological functioning. Neurobiol Aging 2007;28:284-295.
8. Quattrone A, Nicoletti G, Messina D, et al. MR Imaging Index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 2008;246:214-221.
9. Morelli M, Arabia G, Salsone M, et al. Accuracy of magnetic resonance parkinsonism index for differentiation of progressive supranuclear palsy from probable or possible Parkinson disease. Mov Disord 2011;26:527-533.
10. Lehericy S, Hartmann A, Lannuzel A, et al. Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy. Brain 2010;133:2410-2425.
11. Warmuth-Metz M, Naumann M, Csoti I, Solymosi L. Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. Arch Neurol 2001;58:1076-1079.
12. Righini A, Antonini A, De Notaris R, et al. MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. AJNR Am J Neuroradiol 2004;25:927-932.
13. Kato N, Arai K, Hattori T. Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci 2003;210:57-60.
14. Cosottini M, Ceravolo R, Faggioni L, et al. Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging. Acta Neurol Scand 2007;116:37-42.
15. Oba H, Yagishita A, Terada H, et al. New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 2005;64:2050-2055.
16. Groschel K, Kastrup A, Litvan I, Schulz JB. Penguins and hummingbirds: midbrain atrophy in progressive supranuclear palsy. Neurology 2006;66:949-950.
17. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-39.
18. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9.
19. Fahn S, Elton RL. Unified Parkinson's Disease Rating Scale. In: Fahn SMC, Goldstein M, Calne DB, editors. Recent Developments in Parkinson's Disease II. New York: MacMillan; 1987:153-163.
20. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
21. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
22. Nicoletti G, Fera F, Condino F, et al. MR imaging of middle cerebellar peduncle width: differentiation of multiple system atrophy from Parkinson disease. Radiology 2006;239:825-830.
23. Pujol J, Junque C, Vendrell P, Grau JM, Capdevila A. Reduction of the substantia nigra width and motor decline in aging and Parkinson's disease. Arch Neurol 1992;49:1119-1122.
24. Hotter A, Esterhammer R, Schocke MF, Seppi K. Potential of advanced MR imaging techniques in the differential diagnosis of parkinsonism. Mov Disord 2009;24(suppl 2):S711-S720.
25. Hussl A, Mahlknecht P, Scherfler C, et al. Diagnostic accuracy of the magnetic resonance parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy. Mov Disord 2010;25:2444-2449.
26. Jones N. Movement disorders: imaging differentiates progressive supranuclear palsy from Parkinson disease [comment]. Nat Rev Neurol 2011;4:186.
27. Stamelou M, Knake S, Oertel WH, Hoglinger GU. Magnetic resonance imaging in progressive supranuclear palsy. J Neurol 2011;258:549-558.
28. Longoni G, Agosta F, Kostic VS, et al. MRI measurements of brainstem structures in patients with Richardson's syndromes, progressive supranuclear palsy-parkinsonism, and Parkinson's disease. Mov Disord 2011;26:247-255.
29. Arabia G, Quattrone A. MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease. Mov Disord 2011;26:1575-1576.
30. Morelli M, Arabia G, Novellino F, et al. MRI measurements predict PSP in unclassifiable parkinsonisms: a cohort study. Neurology 2011;77:1042-1047.
31. Agosta F, Pievani M, Svetel M, et al. Diffusion tensor MRI contributes to differentiate Richardson's syndrome from PSP-parkinsonism. Neurobiol Aging 2012;33:2817-2826.
32. Brooks DJ, Seppi K. Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Mov Disord 2009;7:949-964.
33. Massey LA, Jager HR, Paviour DC, et al. The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy. Neurology 2013;80:1856-1861.
34. Novellino F, Arabia G, Bagnato A, et al. Combined use of DAT-SPECT and cardiac MIBG scintigraphy in mixed tremors. Mov Disord 2009;24:2242-2248.
35. Buchman AS, Shulman JM, Nag S, et al. Nigral pathology and parkinsonian signs in elders without Parkinson disease. Ann Neurol 2012;71:258-266.
36. Litvan I, Bathia KP, Burn DJ, et al. Movement Disorder Society Scientific Issue Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003;18:467-486.